Glooko Targets Hospital Demand as CMS Elevates Inpatient Glycemic Safety

According to a recent LinkedIn post from Glooko, the company is promoting a March 17 webinar with Becker’s Healthcare focused on inpatient glycemic safety in light of evolving Centers for Medicare & Medicaid Services expectations. The post highlights that CMS is shifting glycemic safety from a general clinical priority to a required performance measure, implying higher scrutiny of hospitals’ glucose and insulin management outcomes.

The LinkedIn post suggests that Glooko is positioning its expertise and solutions around standardizing insulin management and helping hospitals demonstrate consistent, measurable results. For investors, this focus may indicate an effort to deepen engagement with hospital systems facing new regulatory performance pressures, potentially supporting demand for Glooko’s clinical decision support and data-management offerings.

By aligning its educational content with CMS-driven compliance requirements, Glooko could enhance its role in quality improvement initiatives and value-based care programs. This positioning may strengthen the company’s competitive standing in diabetes and glycemic management technology, particularly if hospitals seek scalable tools to meet mandated performance metrics and avoid penalties or lost reimbursement.